(Q33365104)

26 July 2017

Combination chemotherapy of docetaxel and carboplatin in advanced or recurrent cervix cancer. A pilot study (English)

1 reference

26 July 2017

1 reference

1 reference

2

Keiichi Fujiwara

1 reference

26 July 2017

Shoji Nagao

1

1 reference

26 July 2017

Takashi Oda

3

1 reference

26 July 2017

Hiroyasu Ishikawa

4

1 reference

26 July 2017

Hirofumi Koike

5

1 reference

26 July 2017

Hiromasa Tanaka

6

1 reference

26 July 2017

Ichiro Kohno

7

1 reference

26 July 2017

language of work or name

English

0 references

publication date

1 March 2005

1 reference

26 July 2017

1 reference

26 July 2017

96

1 reference

26 July 2017

3

1 reference

26 July 2017

805-809

1 reference

Epidemiology of cervical cancer

26 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.11.044

Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group stud

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.11.044

Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.11.044

Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.11.044

Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.11.044

Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.11.044

Improved treatment for cervical cancer--concurrent chemotherapy and radiotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.11.044

Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.11.044

Neoadjuvant chemotherapy and radical surgery versus exclusive radiotherapy in locally advanced squamous cell cervical cancer: results from the Italian multicenter randomized study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.11.044

In vitro phase II comparison of the cytotoxicity of a novel platinum analog, nedaplatin (254-S), with that of cisplatin and carboplatin against fresh, human cervical cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.11.044

A randomized comparative trial of carboplatin and iproplatin in advanced squamous carcinoma of the uterine cervix: a Gynecologic Oncology Group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.11.044

A phase II trial of carboplatin for recurrent or metastatic squamous carcinoma of the uterine cervix: a Southwest Oncology Group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.11.044

Neoadjuvant treatment of locally advanced carcinoma of the uterine cervix with epirubicin, paclitaxel and cisplatin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.11.044

An update of a phase II study of paclitaxel in advanced or recurrent squamous cell cancer of the cervix

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.11.044

Paclitaxel, an active agent in nonsquamous carcinomas of the uterine cervix: a Gynecologic Oncology Group Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.11.044

Preliminary report of the activity of docetaxel in advanced or recurrent squamous cell cancer of the cervix

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.11.044

Docetaxel as Neoadjuvant Chemotherapy in Patients With Advanced Cervical Carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.11.044

Carboplatin dosage: prospective evaluation of a simple formula based on renal function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.11.044

Neoadjuvant chemotherapy for locally advanced cervical cancer: a systematic review and meta-analysis of individual patient data from 21 randomised trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.11.044

Randomized trial of three cisplatin dose schedules in squamous-cell carcinoma of the cervix: a Gynecologic Oncology Group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.11.044

Paclitaxel has moderate activity in squamous cervix cancer. A Gynecologic Oncology Group study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.11.044

First-line chemotherapy with paclitaxel and platinum for advanced and recurrent cancer of the cervix--a phase II study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.11.044

Phase II trial of carboplatin or iproplatin in cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.11.044

The role of chemotherapy in invasive cancer of the cervix uteri: current standards and future prospects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.11.044

Weekly carboplatin and docetaxel for locally advanced primary and recurrent cervical cancer: a phase I study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.11.044

Early stage I adenocarcinoma of the uterine cervix: treatment results in patients with tumors less than or equal to 4 cm in diameter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.11.044

Combination chemotherapy for metastatic or recurrent adenocarcinoma of the cervix

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.11.044

10.1016/J.YGYNO.2004.11.044

7 January 2021

Identifiers

DOI

1 reference

26 July 2017

1 reference